The Sodium-Glucose Co-Transporter-2 (SGLT2) Inhibitors Reduce Platelet Activation and Thrombus Formation by Lowering NOX2-Related Oxidative Stress: A Pilot Study

• मुख्य लेखकों: Pasquale Pignatelli (लेखक), Francesco Baratta (लेखक), Raffaella Buzzetti (लेखक), Alessandra D'Amico (लेखक), Valentina Castellani (लेखक), Simona Bartimoccia (लेखक), Antonio Siena (लेखक), Luca D'Onofrio (लेखक), Ernesto Maddaloni (लेखक), Annachiara Pingitore (लेखक), Giovanni Alfonso Chiariello (लेखक), Francesca Santilli (लेखक), Daniele Pastori (लेखक), Nicholas Cocomello (लेखक), Francesco Violi (लेखक), Maria Del Ben (लेखक), Vittoria Cammisotto (लेखक), Roberto Carnevale (लेखक)
• स्वरूप: पुस्तक
• प्रकाशित: MDPI AG, 2022-09-01T00:00:00Z.
• विषय: article
• ऑनलाइन पहुंच: Connect to this object online.

Sodium-glucose co-transporter-2 inhibitors or gliflozins, the newest anti-hyperglycemic class, induce cardioprotective benefits in patients with type 2 diabetes (T2D). As platelet activation and oxidative stress play a key role in atherothrombotic-related complications, we hypothesized that gliflozi...